Lanean...
Systemic treatments for metastatic cutaneous melanoma
BACKGROUND: The prognosis of people with metastatic cutaneous melanoma, a skin cancer, is generally poor. Recently, new classes of drugs (e.g. immune checkpoint inhibitors and small‐molecule targeted drugs) have significantly improved patient prognosis, which has drastically changed the landscape of...
Gorde:
| Argitaratua izan da: | Cochrane Database Syst Rev |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2018
|
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491081/ https://ncbi.nlm.nih.gov/pubmed/29405038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011123.pub2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|